A gene variant near ATM is significantly associated with metformin treatment response in type 2 diabetes: a replication and meta-analysis of five cohorts

A gene variant near ATM is significantly associated with metformin treatment response in type 2 diabetes: a replication and meta-analysis of five cohorts

Показать другие версии (1)

Библиографические подробности
Главные авторы:	van Leeuwen, N, Nijpels, G, Becker, M, Deshmukh, H, Zhou, K, Stricker, B, Uitterlinden, A, Hofman, A, van 't Riet, E, Palmer, C, Guigas, B, Slagboom, P, Durrington, P, Calle, R, Neil, A, Hitman, G, Livingstone, S, Colhoun, H, Holman, R, McCarthy, M, Dekker, J, 't Hart, L, Pearson, E
Формат:	Journal article
Опубликовано:	2012

Схожие документы

A gene variant near ATM is significantly associated with metformin treatment response in type 2 diabetes: a replication and meta-analysis of five cohorts.
по: van Leeuwen, N, и др.
Опубликовано: (2012)

A gene variant near ATM is significantly associated with metformin treatment response in type 2 diabetes: a replication and meta-analysis of two Dutch and two UK cohorts
по: 't Hart, L, и др.
Опубликовано: (2011)

The role of ATM in response to metformin treatment and activation of AMPK.
по: Zhou, K, и др.
Опубликовано: (2012)

Rapid emergence of effect of atorvastatin on cardiovascular outcomes in the Collaborative Atorvastatin Diabetes Study (CARDS).
по: Colhoun, H, и др.
Опубликовано: (2005)

Effect of atorvastatin on stroke in the collaborative atorvastatin diabetes study (CARDS): Factors predictive of the risk of stroke
по: Newman, C, и др.
Опубликовано: (2005)

Baseline characteristics in the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with Type 2 diabetes.
по: Thomason, M, и др.
Опубликовано: (2004)

Stroke prediction and stroke prevention with atorvastatin in the Collaborative Atorvastatin Diabetes Study (CARDS).
по: Hitman, G, и др.
Опубликовано: (2007)

Effect of atorvastatin in patients 65 years of age with type 2 diabetes: Subgroup analysis from the collaborative atorvastatin diabetes study (CARDS)
по: DeMicco, D, и др.
Опубликовано: (2005)

Analysis of efficacy and safety in patients aged 65-75 years at randomization: Collaborative Atorvastatin Diabetes Study (CARDS).
по: Neil, H, и др.
Опубликовано: (2006)

Effect of atorvastatin on stroke in patients with type 2 diabetes: factors predicting the risk of stroke in the Collaborative Atorvastatin Diabetes Study (CARDS)
по: Hitman, G, и др.
Опубликовано: (2005)

Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the Collaborative Atorvastatin Diabetes Study (CARDS).
по: Colhoun, H, и др.
Опубликовано: (2009)

Total soluble and endogenous secretory receptor for advanced glycation end products as predictive biomarkers of coronary heart disease risk in patients with type 2 diabetes: an analysis from the CARDS trial.
по: Colhoun, H, и др.
Опубликовано: (2011)

Cost-effectiveness of primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes: results from the Collaborative Atorvastatin Diabetes Study (CARDS).
по: Raikou, M, и др.
Опубликовано: (2007)

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.
по: Colhoun, H, и др.
Опубликовано: (2004)

Change in Lp-PLA2 With Risk Change on Statin Therapy in the Collaborative Atorvastatin Diabetes Study (CARDS)
по: Betteridge, D, и др.
Опубликовано: (2009)

Role of Mitochondria in the Mechanism(s) of Action of Metformin
по: Guillaume Vial, и др.
Опубликовано: (2019-05-01)

Heritability of variation in glycaemic response to metformin: a genome-wide complex trait analysis.
по: Zhou, K, и др.
Опубликовано: (2014)

Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes.
по: Zhou, K, и др.
Опубликовано: (2011)

Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes
по: Zhou, K, и др.
Опубликовано: (2011)

Erratum: Apolipoproteins, cardiovascular risk and statin response in type 2 diabetes: The Collaborative Atorvastatin Diabetes Study (CARDS)
по: Charlton-Menys, V, и др.
Опубликовано: (2009)

Design of the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with type 2 diabetes.
по: Colhoun, H, и др.
Опубликовано: (2002)

Apolipoproteins, cardiovascular risk and statin response in type 2 diabetes: the Collaborative Atorvastatin Diabetes Study (CARDS).
по: Charlton-Menys, V, и др.
Опубликовано: (2009)

Targets of statin therapy: LDL cholesterol, non-HDL cholesterol, and apolipoprotein B in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS).
по: Charlton-Menys, V, и др.
Опубликовано: (2009)

Heritability of variation in glycaemic response to metformin: A genome-wide complex trait analysis
по: Zhou, K, и др.
Опубликовано: (2014)

Cost-effectiveness of atorvastatin (10mg) in patients with type 2 diabetes without coronary heart disease: CARDS trial analysis and extrapolation
по: Raikou, M, и др.
Опубликовано: (2005)

The safety and tolerability of atorvastatin 10 mg in the Collaborative Atorvastatin Diabetes Study (CARDS).
по: Newman, C, и др.
Опубликовано: (2008)

Safety of atorvastatin in the collaborative AtoRvastatin diabetes study (CARDS)
по: Newman, C, и др.
Опубликовано: (2006)

C-reactive Protein and Amyloid A as Predictors of Cardiovascular Events in Type 2 Diabetes in CARDS
по: Charlton-Menys, V, и др.
Опубликовано: (2009)

Alterations in cellular energy metabolism associated with the antiproliferative effects of the ATM inhibitor KU-55933 and with metformin.
по: Mahvash Zakikhani, и др.
Опубликовано: (2012-01-01)

The effect of atorvastatin on serum lipids, lipoproteins and NMR spectroscopy defined lipoprotein subclasses in type 2 diabetic patients with ischaemic heart disease.
по: Soedamah-Muthu, S, и др.
Опубликовано: (2003)

Metformin and mortality. Reply to Lund SS [letter]
по: Stevens, R, и др.
Опубликовано: (2013)

Metformin and mortality. Reply to Lund SS [letter].
по: Stevens, R, и др.
Опубликовано: (2013)

The effect of atorvastatin therapy on tumour necrosis factor-α and vascular adhesion molecules in patients with type 2 diabetes mellitus with no prior history of coronary heart disease
по: Soedamah-Muthu, S, и др.
Опубликовано: (2011)

Metformin and risk of cardiovascular disease.
по: Turner, R, и др.
Опубликовано: (1999)

Risk of anaemia with long-term metformin use in a community setting
по: Donnelly, L, и др.
Опубликовано: (2017)

The sustained influence of metformin therapy on circulating GLP-1 levels in individuals with and without type 2 diabetes
по: Preiss, D, и др.
Опубликовано: (2016)

ANALISIS TERHADAP PERLINDUNGAN HUKUM BAGI NASABAH PENGGUNA ATM (SKIMMING KARTU ATM PADA MESIN ATM BANK X)
по: , Ronald Arthur Saiya, и др.
Опубликовано: (2014)

Identifying the Latitude and Longitude of ATMs in ATM Networks
по: Niloofar Haghjoo, и др.
Опубликовано: (2024-06-01)

The C Allele of ATM rs11212617 Associates With Higher Pathological Complete Remission Rate in Breast Cancer Patients Treated With Neoadjuvant Metformin
по: Elisabet Cuyàs, и др.
Опубликовано: (2019-03-01)

METFORMIN IN THE MANAGEMENT OF TYPE-2 DIABETES - REPLY
по: Holman, R, и др.
Опубликовано: (1989)